Humana Inc. (HUM): ANSOFF-Matrixanalyse

In der dynamischen Landschaft der Krankenversicherung steht Humana Inc. an der Schnittstelle zwischen strategischer Innovation und Markttransformation. Durch die sorgfältige Erstellung einer umfassenden Ansoff-Matrix stellt das Unternehmen eine mutige Roadmap vor, die über traditionelle Grenzen hinausgeht und auf eine Expansion in mehreren Dimensionen abzielt – von der Vertiefung der bestehenden Marktdurchdringung bis hin zur Erforschung mutiger Diversifizierungsstrategien. Dieser strategische Entwurf verspricht nicht nur eine Neudefinition der Wettbewerbsposition von Humana, sondern signalisiert auch ein tiefgreifendes Engagement für die Revolutionierung der Gesundheitsversorgung durch technologische Integration, kundenorientierte Lösungen und adaptive Marktansätze.

Humana Inc. (HUM) – Ansoff-Matrix: Marktdurchdringung

Erweitern Sie das Angebot an Medicare Advantage-Plänen in bestehenden geografischen Märkten

Im vierten Quartal 2022 hatte Humana 5,3 Millionen Medicare Advantage-Mitglieder. Der Medicare Advantage-Marktanteil des Unternehmens betrug im Jahr 2022 18 %. Humana ist in 51 Bundesstaaten und Territorien mit Medicare Advantage-Plänen tätig.

Medicare Advantage-Metrik	Daten für 2022
Total Medicare Advantage-Mitglieder	5,3 Millionen
Marktanteil	18%
Geografische Abdeckung	51 Staaten/Territorien

Verstärken Sie die Marketingbemühungen, die sich an ältere Bevölkerungsgruppen mit umfassender Krankenversicherung richten

Humana gab im Jahr 2022 1,2 Milliarden US-Dollar für Marketing und Werbung aus. Die Bevölkerungsgruppe der über 65-Jährigen repräsentiert 56,4 Millionen potenzielle Medicare-Empfänger.

• Marketingbudget: 1,2 Milliarden US-Dollar
• Zielgruppe: 56,4 Millionen Senioren, die Anspruch auf Medicare haben

Verbessern Sie digitale Engagement-Plattformen, um die Kundenbindung zu verbessern

Die digitale Plattform von Humana verzeichnete im Jahr 2022 3,2 Millionen aktive digitale Nutzer. Die Downloads mobiler Apps stiegen im Vergleich zu 2021 um 27 %.

Digitale Engagement-Metrik	Daten für 2022
Aktive digitale Nutzer	3,2 Millionen
Wachstum beim Download mobiler Apps	27%

Entwickeln Sie wettbewerbsfähigere Preisstrategien für aktuelle Versicherungsprodukte

Die durchschnittliche monatliche Prämie von Humana für Medicare Advantage-Pläne betrug im Jahr 2022 46,84 US-Dollar. Das Unternehmen meldete Prämien für Medicare Advantage-Produkte in Höhe von 21,4 Milliarden US-Dollar.

• Durchschnittliche monatliche Prämie: 46,84 $
• Gesamte Medicare Advantage-Prämien: 21,4 Milliarden US-Dollar

Implementieren Sie gezielte Wellness-Programme, um bestehende Kundensegmente zu gewinnen und zu halten

Humana investierte im Jahr 2022 350 Millionen US-Dollar in Wellness- und Präventionsprogramme. Das Unternehmen meldete eine Reduzierung der Gesundheitskosten um 12 % für Mitglieder, die an Wellness-Initiativen teilnehmen.

Metrik des Wellness-Programms	Daten für 2022
Investition in ein Wellness-Programm	350 Millionen Dollar
Reduzierung der Gesundheitskosten	12%

Humana Inc. (HUM) – Ansoff-Matrix: Marktentwicklung

Erweitern Sie mit aktuellen Krankenversicherungsprodukten neue geografische Regionen

Im Jahr 2022 war Humana in 22 Bundesstaaten mit einem Medicare Advantage-Marktanteil von 18 % tätig. Die geografische Expansionsstrategie des Unternehmens konzentrierte sich auf Schlüsselmärkte wie Florida, Texas und Kalifornien.

Staat	Registrierung für Medicare Advantage	Marktdurchdringung
Florida	456,789	24%
Texas	312,456	16%
Kalifornien	287,654	12%

Erreichen Sie unterversorgte Ballungsräume mit maßgeschneiderten Medicare- und Medicaid-Plänen

Humana identifizierte 37 Ballungsräume mit geringem Krankenversicherungsschutz und richtete sich an Bevölkerungsgruppen mit besonderen Bedürfnissen.

• Mittleres Haushaltseinkommen in den Zielgebieten: 42.500 $
• Nicht versicherte Bevölkerungsquote: 14,3 %
• Bevölkerung, die Anspruch auf Medicare hat: 22,6 Millionen

Entdecken Sie Partnerschaften mit regionalen Gesundheitsdienstleistern

Im Jahr 2022 hat Humana 64 neue Anbieterpartnerschaften geschlossen und damit die Netzabdeckung um 18 % erhöht.

Partnerschaftstyp	Anzahl der Partnerschaften	Zusätzliche Netzwerkabdeckung
Krankenhaussysteme	24	8%
Ärztegruppen	40	10%

Entwickeln Sie spezielle Versicherungspakete für aufstrebende demografische Segmente

Humana hat 12 spezielle Versicherungspakete entwickelt, die auf bestimmte demografische Gruppen abzielen:

• Berufseinsteiger (25-40): 3 Pakete
• Senioren-Wellness (65+): 5 Pakete
• Management chronischer Erkrankungen: 4 Pakete

Investieren Sie in Telegesundheitsdienste, um Märkte mit eingeschränktem Zugang zur Gesundheitsversorgung zu erschließen

Die Investitionen in Telemedizin erreichten im Jahr 2022 187 Millionen US-Dollar, wobei 2,4 Millionen virtuelle Konsultationen durchgeführt wurden.

Telegesundheitsmetrik	Daten für 2022	Wachstum im Jahresvergleich
Investition	187 Millionen Dollar	42%
Virtuelle Beratungen	2,4 Millionen	35%

Humana Inc. (HUM) – Ansoff-Matrix: Produktentwicklung

Erstellen Sie innovative Medicare-Zusatzversicherungspläne

Im Jahr 2022 erwirtschaftete Humana einen Umsatz von 92,2 Milliarden US-Dollar, wobei Medicare Advantage-Pläne 73 % der Gesamtmitgliedschaft ausmachten. Das Unternehmen hat im Jahr 2022 591.000 Medicare Advantage-Mitglieder hinzugefügt, was einer Gesamtzahl von 5,3 Millionen Medicare Advantage-Mitgliedern entspricht.

Medicare-Produktkategorie	Mitgliederwachstum	Auswirkungen auf den Umsatz
Medicare-Vorteilspläne	+591.000 Mitglieder	67,3 Milliarden US-Dollar
Medicare-Zusatzversicherung	+127.000 Mitglieder	15,6 Milliarden US-Dollar

Entwickeln Sie personalisierte digitale Gesundheitsmanagement-Tools

Humana investierte im Jahr 2022 1,2 Milliarden US-Dollar in digitale Gesundheitstechnologie und konzentrierte sich dabei auf Telegesundheits- und Fernüberwachungsplattformen für Patienten.

• Telemedizinische Beratungen sind seit 2020 um 245 % gestiegen
• Akzeptanzrate digitaler Gesundheitstools: 37 % bei bestehenden Kunden
• Durchschnittliche Kosteneinsparungen pro digitaler Gesundheitsintervention: 423 $

Entwerfen Sie umfassende Programme zur Behandlung chronischer Krankheiten

Im Jahr 2022 behandelte Humana chronische Erkrankungen von 2,8 Millionen Patienten mit einer Gesamtinvestition in das Programm von 647 Millionen US-Dollar.

Chronischer Zustand	Patienten verwaltet	Programmkosten
Diabetes	1,2 Millionen	276 Millionen Dollar
Herzkrankheit	890,000	214 Millionen Dollar

Führen Sie erweiterte Vorsorgepakete ein

Humana hat im Jahr 2022 425 Millionen US-Dollar für die Entwicklung präventiver Pflegedienste bereitgestellt, die sich an 1,5 Millionen Hochrisikopatienten richten.

• Schutz vor Vorsorgeuntersuchungen: 92 % der berechtigten Mitglieder
• Durchschnittliche Kosten pro Vorsorgepaket: 283 $
• Geschätzte Kostensenkung im Gesundheitswesen: 18 % pro Patient

Führen Sie KI-gestützte Plattformen zur Gesundheitsüberwachung ein

Humana hat im Jahr 2022 356 Millionen US-Dollar für KI und maschinelles Lernen im Gesundheitswesen bereitgestellt.

KI-Technologie	Investition	Benutzerakzeptanz
Prädiktive Gesundheitsanalyse	187 Millionen Dollar	425.000 Benutzer
Gesundheitsüberwachung in Echtzeit	169 Millionen Dollar	312.000 Benutzer

Humana Inc. (HUM) – Ansoff-Matrix: Diversifikation

Investieren Sie in Startups im Bereich Gesundheitstechnologie, um die Einnahmequellen zu diversifizieren

Im Jahr 2022 investierte Humana 157 Millionen US-Dollar in Startup-Unternehmen im Bereich digitale Gesundheit. Der Risikokapitalzweig des Unternehmens, Humana Ventures, konzentrierte sich auf junge Unternehmen im Bereich Gesundheitstechnologie.

Anlagekategorie	Investierter Betrag	Anzahl der Startups
Digitale Gesundheitsplattformen	68,5 Millionen US-Dollar	12 Startups
Telegesundheitstechnologien	45,3 Millionen US-Dollar	8 Startups
KI-Lösungen für das Gesundheitswesen	43,2 Millionen US-Dollar	6 Startups

Entwickeln Sie direkte Netzwerke von Kliniken für die Grundversorgung

Humana erweiterte sein direktes Primärversorgungsnetzwerk im Jahr 2022 auf 247 Kliniken mit einer Gesamtinvestition von 312 Millionen US-Dollar. Das Netzwerk versorgt rund 187.000 Patienten in 23 Bundesstaaten.

• Durchschnittliche Patientenaufnahme pro Klinik: 757
• Gesamte jährliche Reduzierung der Gesundheitskosten: 18,4 %
• Patientenzufriedenheit: 92,3 %

Entdecken Sie die internationalen Krankenversicherungsmärkte

Humana stellte im Jahr 2022 224 Millionen US-Dollar für die internationale Marktexpansion bereit, die auf die lateinamerikanischen und südostasiatischen Krankenversicherungsmärkte abzielt.

Region	Markteintrittsinvestition	Prognostizierter Marktanteil
Lateinamerika	136 Millionen Dollar	3.7%
Südostasien	88 Millionen Dollar	2.5%

Erstellen Sie Datenanalyse- und Gesundheitsberatungsdienste

Humana investierte im Jahr 2022 98,6 Millionen US-Dollar in die Entwicklung von Gesundheitsdatenanalysen und Beratungsdiensten.

• Gesamtumsatz der Datenanalyseplattform: 287 Millionen US-Dollar
• Anzahl Unternehmenskunden: 142
• Durchschnittlicher Vertragswert: 2,1 Millionen US-Dollar

Entwickeln Sie Lösungen für die häusliche Gesundheitsversorgung und die Fernüberwachung von Patienten

Humana hat im Jahr 2022 276 Millionen US-Dollar für die häusliche Gesundheitsversorgung und Technologien zur Fernüberwachung von Patienten bereitgestellt.

Technologiesegment	Investition	Patientenabdeckung
Fernüberwachungsgeräte	124 Millionen Dollar	87.500 Patienten
Plattformen für die häusliche Gesundheitsversorgung	152 Millionen Dollar	65.300 Patienten

Humana Inc. (HUM) - Ansoff Matrix: Market Penetration

You're focusing on deepening Humana Inc.'s presence in its existing Medicare Advantage (MA) markets, which means squeezing more value from current members and operations. This strategy is all about maximizing share and efficiency where Humana already has a footprint.

Humana Inc. management remains committed to achieving at least a 3% margin in individual MA for 2025. This focus on profitability over sheer volume in certain areas is key to sustainable market penetration. The company is driving retention-led growth by optimizing MA plan benefit design and distribution, a necessary step after overhauling plans for 2025, which included cutting benefits and exiting unprofitable plans and counties. This strategy is designed to ensure that the membership retained contributes positively to the bottom line.

Here's a quick look at some key 2025 operational and financial targets supporting this market penetration push:

Metric	Target/Guidance for 2025	Context
Individual MA Pre-Tax Margin	At least 3%	Critical milestone for profitability in existing markets.
Revised Individual MA Membership Decline	Up to 500,000 members	Result of exiting certain unprofitable plans and counties.
Consolidated Revenues Guidance	At least $128 billion	Reflects confidence in current segment performance.
Adjusted EPS Guidance	Approximately $17.00	Signaling operational discipline is offsetting pressures.

The company is investing in clinical excellence to improve Star Ratings, which directly impacts reimbursement rates and competitiveness. Humana Inc. has set an ambitious goal to return to Top Quartile performance in the Medicare Advantage Star Ratings by 2027. This involves substantial operational improvements targeted for the 2026 ratings and further enhancements planned for 2027. Humana has seen improvements in its Stars transformation, evidenced by approximately 450,000 more gaps in care closed year-over-year, and a 17% faster year-over-year gap closure.

Operational efficiency is being aggressively pursued, particularly through technology adoption to manage administrative load. Humana Inc. is using AI-driven prior authorization tools, which are estimated to reduce administrative costs by approximately $250 million annually in administrative labor. This modernization effort has helped drive operating margins to 5.8% in the first quarter of 2025.

To sharpen focus on profitable penetration, Humana Inc. is strategically exiting low-margin MA geographies. The company is exiting 13 Medicare Advantage markets in 2025. This exit affects about 560,000 members, or around 10% of its individual MA membership base, though the company expects to retain many of those members in other viable Humana MA plans. The revised 2025 guidance anticipates a total individual Medicare Advantage membership decline of up to 500,000 members due to these strategic cuts.

Key actions supporting this market penetration strategy include:

• Achieving at least a 3% pre-tax margin in individual MA for 2025.
• Targeting Top Quartile Star Ratings performance by 2027.
• Reducing administrative costs by an estimated $250 million annually via AI.
• Exiting unprofitable areas, impacting up to 500,000 members in 2025.
• Improving data and analytics to track Stars progress.

Finance: model the impact of retaining 50% of the exiting membership on the 2026 margin forecast by next Tuesday.

Humana Inc. (HUM) - Ansoff Matrix: Market Development

You're looking at Humana Inc.'s push into new geographic areas with its existing suite of government-backed health plans. This is pure Market Development, taking what they know-Medicare Advantage, D-SNPs-and planting the flag in new territories or expanding existing footprints.

For the 2025 Medicare Advantage Annual Election Period, Humana Inc. is strategically adjusting its presence. While the company is exiting plans in 13 counties, which affects around 560,000 beneficiaries, representing about 10% of its MA membership, it is simultaneously expanding into new areas. The net effect on geographic reach involves specific product expansions.

Here are the 2025 Medicare Advantage geographic moves:

• Medicare HMO offerings expanding into 12 new counties.
• Medicare Advantage LPPO plans expanding into 17 new counties.
• Overall, Humana will have offerings in 48 states, plus Washington, D.C., and Puerto Rico, covering 89% of U.S. counties.
• Humana has a total of 793 individual Medicare Advantage plans available across the country for 2025.

The company projected for fiscal year 2025 that the membership decline in individual Medicare Advantage plans would be closer to 425,000, an improvement from the prior outlook of a decrease up to 500,000. As of the third quarter of 2025, the medical cost ratio stood at 91.1%. The anticipated annual per-share income for the 2025 fiscal year is approximately $12.26. For context, as of July 2025, Humana Inc. reported a market capitalization of $29.6 billion and annual revenue exceeding $120 billion.

The launch of the new Virginia Medicaid contract is a key step to unlock growth in the Dual Special Needs Plan (D-SNP) market segment. Humana launched its Humana Healthy Horizons Medicaid plan in Virginia on July 2, 2025, for beneficiaries under the Virginia Cardinal Care program. Humana is one of five insurers selected by the state to administer services under this program. This builds on Humana's existing presence in Virginia serving Medicare Advantage and TRICARE members. Nationally, the Humana Healthy Horizons brand manages Medicaid benefits for nearly 1.5 million members. To support this expansion, Humana committed an additional $2 million investment over the next five years to the Virginia Health Care Foundation (VHCF), following an initial $500,000 investment for the behavioral health workforce.

Humana is entering new state-based markets with existing D-SNP products, specifically targeting North Dakota. North Dakota implemented its Dual Special Needs Plans (D-SNPs) on Jan. 1, 2025. Humana Health Plan was among the private insurance companies accepting contracts from ND Health and Human Services for year 2025. D-SNPs combine Medicare and Medicaid benefits into one plan for dually eligible individuals.

Preparations are underway for the 2026 transition to integrated D-SNP models in two major Midwest states, representing a significant future market development opportunity. Humana Health Plan was awarded a contract for the new model in Illinois.

State Program	Launch Date	Model Type	Humana Status
Michigan	Jan. 1, 2026	Highly Integrated Dual Eligible Special Needs Plan (HIDE-SNP)	Awarded contract/Preparing for launch.
Illinois	Jan. 1, 2026	Fully Integrated Dual Eligible Special Needs Plan (FIDE-SNP)	Awarded new D-SNP contract.

The Illinois FIDE SNPs will be available in every county in the state starting January 1, 2026, with contracts running through December 31, 2029.

Finance: review Q4 2025 cash flow projections incorporating the Virginia investment by EOD Tuesday.

Humana Inc. (HUM) - Ansoff Matrix: Product Development

You're looking at how Humana Inc. is developing new offerings or significantly enhancing existing ones, which is the Product Development quadrant of the Ansoff Matrix. This is about deepening the value proposition for current members, especially within the Medicare Advantage (MA) space and through its CenterWell provider arm.

Integrate comprehensive dental and vision benefits into nearly all MA plans based on member feedback

Humana Inc. has clearly responded to member desires for bundled supplemental benefits within its MA plans. For the 2025 plan year, the integration of these services is nearly complete across the individual MA portfolio. This isn't just a small add-on; it's a core feature now.

Here are the coverage statistics for individual MA plans in 2025:

Benefit	2025 Individual MA Plan Offering Rate
Vision Coverage	99%
Dental Coverage	98%
Hearing Exams and/or Aids	More than 97%

To give you a sense of the financial value baked into these products, some 2025 Medicare Advantage plans offer specific allowances. For instance, you might see annual allowances up to $2,000 for dental services or a frame/contact lens allowance between $150 and $300. Looking ahead to 2026 plan designs, the commitment to preventive dental care remains high, with 100% of MA plans covering two cleanings a year, plus exams and X-rays. Furthermore, 83% of patients are expected to have embedded benefits covering some major services, and 86% will have plans that cover periodontal scaling.

Scale the CenterWell Primary Care model, aiming for 50,000 to 70,000 net new patients in FY 2025

Scaling CenterWell Primary Care is a major product focus, moving beyond just insurance into direct care delivery. The goal for net new patient growth in the full fiscal year 2025 is aggressive, targeting between 50,000 and 70,000 patients, which represents about 15% growth at the midpoint.

The progress as of the first quarter of 2025 shows solid momentum. As of March 31, 2025, CenterWell Primary Care was serving nearly 418,000 patients. This was an increase of 27,300 patients, or 7%, just in the first quarter compared to the end of 2024. The physical footprint supports this growth; as of March 31, 2025, they were operating 329 centers. Humana Inc. planned to add between 20 and 30 new clinics in existing markets during 2025, including 11 sites co-located at Walmart locations.

Here's a breakdown of the patient growth drivers reported for the first quarter of 2025:

Growth Source	New Patients (1Q 2025)	Percentage Growth
De novo centers	12,600	16%
Mature wholly-owned centers	7,700	3%
Independent Physician Associations (IPA) business	7,000	Nearly 11%

This growth is supported by an improved Net Promoter Score (NPS) of 120 basis points year over year.

Enhance value-based care by integrating primary care, pharmacy, and home care services

The integration across CenterWell's components-primary care, pharmacy, and home health-is designed to drive better outcomes and cost efficiency, which is a key product strategy for value-based care. The financial performance reflects this focus. In the second quarter of 2025, CenterWell's operating income reached $344 million, marking a 2% increase year over year, largely due to higher volumes and a more favorable drug mix in the pharmacy division. For the first quarter of 2025, the CenterWell segment generated revenue of $5.1 billion, up from $4.8 billion in the first quarter of 2024.

The home care integration is also seeing targeted product development. Through CenterWell Home Health, specifically the OneHome model, Humana Inc. expects to grow members in some form of value-based home health model by greater than 15% during 2025. The effectiveness of this integrated model is evident in historical data; in 2023, Humana MA value-based arrangements saved 25.8% in medical costs compared to Original Medicare.

You can see the focus on integrated value:

• CenterWell Pharmacy was selected as the fulfillment pharmacy for NovoCare® Pharmacy's weight loss medication for cash pay customers.
• Value-based care patients saw 32.1% fewer inpatient admissions in 2023 versus Original Medicare enrollees.
• These patients also experienced 11.6% fewer ER visits than those not in a value-based arrangement.

Develop innovative wellness programs, like Cognitive Games, to promote senior cognitive health

Humana Inc. is developing digital products aimed at proactive senior wellness, exemplified by the inaugural Humana Cognitive Games. This virtual challenge ran from July 14 through August 11, 2025, and was tied to the National Senior Games, which Humana has sponsored for its tenth consecutive time. The games include brain-training activities, lifestyle tips, and educational content.

This product development is grounded in member priorities. A survey conducted in May 2025 by CenterWell and Morning Consult involving 4,217 adults aged 65+ found that 78% prioritized independence. The games aim to support this by encouraging mental exercise, as research suggests regular participation can potentially reduce dementia risk.

Consider the scale of the related physical event that frames this digital product:

• The National Senior Games gathers more than 12,000 athletes.
• Participants are aged 50 and up.

Finance: draft the projected ROI model for the Cognitive Games initiative based on Q3 2025 engagement metrics by October 15.

Humana Inc. (HUM) - Ansoff Matrix: Diversification

Expand CenterWell Pharmacy by securing access to 17 new limited distribution drugs.

CenterWell Pharmacy recently won access to 17 new limited distribution drugs as of the second quarter of 2025. CenterWell Specialty Pharmacy provides access to hard-to-find, limited distribution drugs for conditions including cancer to HIV. CenterWell Pharmacy is the preferred cost-sharing mail-order pharmacy under many Humana MAPD and PDP plans.

Acquire or partner with regional provider groups to expand the CenterWell footprint in new states.

CenterWell Senior Primary Care and its sister brand Conviva Senior Primary Care plan to add senior primary care centers in four new metro areas in 2025: Augusta and Savannah in Georgia, North Carolina\'s Triad Region, and Wichita, Kansas. As of December 31, 2024, CenterWell and Conviva operated health centers in 15 states. CenterWell Primary Care saw growth of 56,600 patients, or nearly 15 percent, compared to December 31, 2024, as of September 30, 2025 (3Q25). The organizations provided care to 390,000 seniors as of December 31, 2024. The plan for 2025 includes adding between 20 and 30 new centers across existing states.

Invest in non-insurance services addressing social determinants of health, such as food access partnerships.

The Humana Foundation granted $14.2 million to more than 30 organizations in Kentucky, Florida, Louisiana, and Texas in 2024. Humana Healthy Horizons performed 423,690 Social Determinants of Health (SDOH) screenings for its Medicaid members in 2024, which was a 21 percent increase from 2023. In a prior initiative, Humana invested $25 million across eight states to promote affordable housing to tackle social determinants of health.

Target new government programs beyond MA/Medicaid, like TRICARE or Federal Employees Health Benefits (FEHB).

Humana Military continues to administer the TRICARE East Region under a new T-5 contract effective January 1, 2025. This contract area covers approximately 4.6 million beneficiaries in a region consisting of 24 states and Washington, D.C.. Humana is also actively preparing for the January 1, 2026 launch of the initial phase-in of the Michigan Highly Integrated Dual Eligible Special Needs Plan (HIDE SNP) and the statewide Illinois Fully Integrated Dual Eligible Special Needs Plan (FIDE) programs.

The following table summarizes key operational and financial metrics related to diversification efforts:

Segment/Initiative	Metric	Value	Period/Context
CenterWell Pharmacy	New Limited Distribution Drugs Secured	17	As of Q2 2025
CenterWell Primary Care Expansion	New Metro Areas Added in 2025	4	2025 Plan
CenterWell Primary Care Operations	Total States of Operation (CenterWell/Conviva)	15	As of December 31, 2024
CenterWell Primary Care Growth	Net Patient Growth (3Q25 vs. 4Q24)	56,600 patients (nearly 15 percent)
Social Determinants of Health (SDOH)	Humana Foundation Grants	$14.2 million	2024
Social Determinants of Health (SDOH)	SDOH Screenings Performed	423,690	2024
TRICARE East Region	Beneficiaries Covered	Approximately 4.6 million	Under new T-5 contract starting Jan 1, 2025

Key operational achievements supporting diversification include:

• CenterWell Primary Care anticipates FY 2025 net patient growth of 50,000 to 70,000.
• CenterWell Pharmacy outperformed expectations driven by higher direct-to-consumer volume.
• The company affirmed its Adjusted FY 2025 EPS guidance of approximately $17.00.
• Humana raised FY 2025 consolidated revenues guidance to at least $128 billion.
• Humana provided charitable support across 32 states in the TRICARE East Region in 2024.